Mary Lou Lubin

Title: **Mary Lou Lubin: Innovator in Canine Sensory Receptors**

Introduction

Mary Lou Lubin, an accomplished inventor based in Norristown, PA, has made significant contributions to the field of veterinary science through her innovative work on canine sensory receptors. With a patented breakthrough, she has opened new avenues for understanding how dogs perceive certain stimuli, fundamentally enhancing detection and screening methods in veterinary applications.

Latest Patents

Mary Lou Lubin holds a patent for the invention titled "Canine Cold- and Menthol-Sensitive Receptor 1." This groundbreaking patent describes the nucleic acid and polypeptide sequences associated with a novel canine cold- and menthol-sensitive receptor, referred to as canine CMR1 (cCMR1). The isolated nucleic acid or polypeptide molecules delineated in the patent provide significant potential for use in detection and screening assays, paving the way for advancements in canine health assessments.

Career Highlights

Mary Lou Lubin is currently employed at Janssen Pharmaceutica NV, a leading company in pharmaceutical innovation. Her role involves extensive research and development efforts to explore and enhance canine sensory functions. Through her work, she contributes to the company’s mission of advancing healthcare solutions that improve animal well-being.

Collaborations

Lubin has collaborated with notable peers, including Christopher M. Flores and Yi Liu. Together, they work to further the understanding of canine sensory systems and the associated applications of their research, thereby fostering a collaborative environment that drives innovation in veterinary science.

Conclusion

Mary Lou Lubin's contributions to the field of canine sensory receptors reflect her dedication to advancing veterinary science. Her patented invention offers valuable insights and practical applications that can significantly improve how dogs are understood and cared for in the realm of veterinary medicine.